Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T15:37:11.083Z.
Calculation as of: 2026-10-06T15:37:11.083Z.
Quote observation: 2026-10-06T15:35:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2eba736d2827de544c9f141b3fafa3dea8ffa5f0a614b8c2b2ac1915a5af89f6
EARNINGS YIELD
N/A
Century Therapeutics, Inc.
Market Cap
$256.22M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$258.56M
Earnings Yield
N/A
TTM Avg
1.20%
3Y Avg
4.13%
5Y Avg
3.97%
Market Cap
$262.11M
Earnings Yield
N/A
TTM Avg
24.17%
3Y Avg
24.17%
5Y Avg
24.17%
Market Cap
$249.41M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$263.39M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$264.62M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | $256.22M | N/A | N/A | N/A | N/A |
| Anika Therapeutics, Inc. (ANIK)vs › | $258.56M | N/A | 1.20% | 4.13% | 3.97% |
| AC Immune S.A. (ACIU)vs › | $260.03M | N/A | 8.07% | 8.07% | 7.35% |
| Quantum-Si incorporated (QSI)vs › | $252.22M | N/A | N/A | N/A | N/A |
| Palisade Bio, Inc. (PALI)vs › | $262.11M | N/A | 24.17% | 24.17% | 24.17% |
| Nautilus Biotechnolgy, Inc. (NAUT)vs › | $249.41M | N/A | N/A | N/A | N/A |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $263.39M | N/A | N/A | N/A | N/A |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $264.62M | N/A | N/A | N/A | N/A |
| Invivyd, Inc. (IVVD)vs › | $247.82M | N/A | N/A | N/A | N/A |
| Q32 Bio Inc. (QTTB)vs › | $247.49M | 33.55% | 26.39% | 26.39% | 30.90% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
